SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells

PURPOSE: We previously demonstrated an association between decreased SMAD4 expression and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to further elucidate the clinical relevance of SMAD4 loss in HNSCC. EXPERIMENTAL DESIGN: SMAD4 expression was...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Ozawa, Hiroyuki, Ranaweera, Ruchira, Izumchenko, Evgeny, Makarev, Eugene, Zhavoronkov, Alex, Fertig, Elana J., Howard, Jason D., Markovic, Ana, Bedi, Atul, Ravi, Rajani, Perez, Jimena, Le, Quynh-Thu, Kong, Christina S., Jordan, Richard C., Wang, Hao, Kang, Hyunseok, Quon, Harry, Sidransky, David, Chung, Christine H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078415/
https://ncbi.nlm.nih.gov/pubmed/28522603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1686
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller